RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
27 hedge funds and large institutions have $11.3M invested in Regulus Therapeutics in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Holders
27
Holding in Top 10
–
Calls
$7K
Puts
–
Top Buyers
| 1 | +$2.31M | |
| 2 | +$1.42M | |
| 3 | +$1.39M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$1.23M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$1.13M |
Top Sellers
| 1 | -$68K | |
| 2 | -$38.7K | |
| 3 | -$16K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$14K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$12.7K |